Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5705_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •1.1.4 Components of niosome
- •1.1.5 Factors affecting niosomes
- •Preface
- •Abstract
- •1.1 Introduction
- •1.1.1 Why niosome?
- •1.1.2 Advantages of niosome
- •1.1.3 Structure of niosome
- •1.2 Applications of niosome
- •1.2.2 Niosomes for the delivery of therapeutics
- •1.2.3 Niosomes in biomedical applications
- •1.3 Conclusions and future prospects
- •Keywords
- •References
- •Abstract
- •2.1 Introduction
- •2.2 Conclusions
- •Acknowledgments
- •Keywords
- •References
- •Abstract
- •3.1 Introduction
- •3.2.1 Parameters involved in electrospinning process
- •3.2.2 Biomaterials for electrospinning
- •3.3 Electrospun nanofibers as drug delivery systems
- •3.3.1 Blending electrospinning
- •3.3.2 Emulsion electrospinning
- •3.3.3 Coaxial electrospinning
- •3.3.4 Surface modifications
- •3.4 Electrospun nanofibers for tissue engineering
- •3.4.1 Electrospun nanofibers for hard tissue engineering
- •3.5 Cancer diagnosis and therapy
- •3.6 Concluding remarks and future perspectives
- •Keywords
- •References
- •4. Natural Biocarriers for Brain Targeting
- •Abstract
- •4.1 Introduction
- •4.1.1 Central nervous system
- •4.2 Biocarriers
- •4.2.1 Carbohydrates carriers
- •4.2.2 Protein carriers
- •4.2.3 Exosomes
- •4.3 Conclusions and perspectives
- •Keywords
- •References
- •Abstract
- •5.1 Introduction
- •5.2 Synthesis of graphene family nanomaterials
- •5.2.1 Graphene synthesis
- •5.2.2 GO and rGO Syntheses
- •5.2.3 GQd synthesis
- •5.4 Drug delivery and biomedical applications
- •5.4.1 Drug delivery
- •5.4.2 Gene delivery
- •5.4.3 Bioimaging
- •5.4.4 Photothermal therapy
- •5.4.5 Tissue engineering
- •5.5 Summary and future prospect
- •Keywords
- •References
- •6. Nanotechnology in Gene Delivery
- •Abstract
- •6.1 Introduction
- •6.2 Gene delivery
- •6.3 Nanotechnology in gene delivery
- •Keywords
- •References
- •Abstract
- •7.1 Introduction
- •7.2 Additive manufacturing in pharmacology
- •7.2.1 Extrusion-based 3D printing techniques
- •7.2.2 Stereolithography
- •7.2.3 Selective laser sintering
- •7.2.4 Binder jet printing
- •7.3 Most common polymers
- •7.3.1 Natural polymers
- •7.3.2 Synthetic polymers
- •7.3.2.5 Polyvinylpyrrolidone
- •7.4 Common 3D-printed dosage forms
- •7.4.1 Scaffolds
- •7.4.2 Tablets
- •Keywords
- •References
- •7.4.3 Microneedles
- •7.4.4 Capsule
- •7.4.5 Films
- •7.5 Main factors in drug delivery
- •7.5.1 Nature of polymers
- •7.5.2 Matrix permeability
- •7.5.3 Polymer blends
- •7.5.4 Specific surface area
- •7.5.5 Infill density and patterns
- •7.5.6 Pores
- •7.5.7 Cross-linking
- •7.5.8 Coating
- •7.5.9 Core/shell and multicompartment
- •7.6 Final considerations and future perspectives
- •Abstract
- •8.1 Introduction
- •8.2.1 Polymer solution concentration and viscosity
- •8.2.2 Molecular weight of polymer
- •8.2.3 Surface tension
- •8.2.4 Electrical conductivity
- •8.2.5 Applied voltage
- •8.2.6 Feed rate/flow rate
- •8.2.7 Temperature and humidity
- •8.3 Method of preparation for nanofibers
- •8.3.1 Electrospinning
- •8.3.2 Self-assembly
- •8.3.3 Phase separation
- •8.3.4 Drawing of nanofibers
- •8.3.5 Template synthesis
- •8.4 Biomedical applications of nanofibers
- •8.4.1 Wound dressing
- •8.4.2 Tissue engineering
- •8.4.3 In cancer therapy
- •8.4.4 Miscellaneous
- •8.5 Drug delivery application
- •8.5.1 Antihypertensive drug
- •8.5.2 Antimicrobial drug
- •8.5.3 Growth hormone
- •8.5.4 Miscellaneous
- •8.6 Conclusion
- •Keywords
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Tissue engineering
- •9.3 Nanotechnology
- •9.4 Polymeric scaffolds in tissue engineering
- •9.5 Challenges
- •Keywords
- •References
- •Abstract
- •10.1 Introduction
- •10.2 Ideal properties of bioceramics
- •10.2.1 Mechanical property
- •10.2.2 Porosity, pore size, and shape
- •10.2.3 Biocompatibility and biodegradability
- •10.2.4 Osteoconductivity and osseointegrity
- •10.3 Bioceramics in orthopedic applications
- •10.4 Bioceramics in maxillofacial surgery
- •10.5 Bioceramic in drug delivery applications
- •10.6 Doped bioceramic in biomedical application
- •10.7 Conclusions
- •10.8 Future direction
- •Acknowledgments
- •Keywords
- •References
- •Index

88
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
molecule antibody (anti-EpCAM), HA, and DNA aptamer have been used to
possibility to translate tissue engineering principles and methods into cancer
research, to provide physiologically relevant 3D in vitro cancer models (Cavo
aims to explore cancer pathogenesis, drug discovery , and evolution in a more
realistic environment than 2D cultures or animal models. In this context,
-
the tumor ECM and microenvironment (Erickson et al., 2022).
3.6 CONCLUDING REMARKS AND FUTURE PERSPECTIVES
In conclusion, electrospinning technology has demonstrated great capability
-
critical issues have remained unsolved in clinical translation including
in

Electrospun Technology for Drug Delivery and Biomedical Applications
89
vivo
In summary, tissue repair and regeneration are complex processes that, in
clinical applications.
KEYWORDS
• electrospinning
• electrospun nanofibers
• drug delivery
• tissue engineering
• cancer theranostics
REFERENCES
Mater. Sci. Eng. C 2019, 97, 966–977.
J. Microencapsulation. 2011, 28 (4), 323–335.
Acta Biomater.
2018, 74, 464–477.
Controlled Drug Release. Int. J. Pharm. 2020, 584, 119435.
Biomedical Applications. Nanomaterials 2018, 8 (4), 259.
Regenerative Medicine. Int. J. Mol. Sci. 2022, 23 (16), 9206.
Clin. Oral Investig.
2022, 26 (5), 4031–4047.

90
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
J. Food Sci. 2010, 75 (6), N80–N88.
Artif. Cells
Nanomed. Biotechnol. 2017, 45 (2), 185–192.
Analyst 2020, 145 (8), 2854–2872.
Material: Structure and Function. Acta Biomater. 2009, 5 (1), 1–13.
Mater. Sci. Eng. C 2017, 81, 459–468.
Drug Delivery Systems. Pharma Innov. 2012, 1 (10).
Int. J. Mol.
Sci. 2023, 24 (4), 3172.
Polym. Adv.
Technol. 2016, 27 (11), 1404–1412.
J. Biomater. Sci. Polym. Ed.
2014, 25 (4), 325–340.
Langmuir 2012, 28 (38), 13675–13687.
Support Viability In Vitro. Acta Biomater. 2018, 73, 217–227.
Biomater. Sci. 2020, 8 (18), 4887–4905.
J. Biomater. Sci. Polym. Ed. 2019,
30 (14), 1308–1355.
Acta Biomater. 2018, 80, 154–168.
Electrospinning Block Copolymers. Soft Matter. 2019, 15 (12), 2490–2510.
in Cancer Research. Adv. Healthc. Mater. 2018, 7 (6), E1701024.
Biomater. Sci. 2016, 4 (6), 922–932.
Mater. Sci. Eng. C 2018,
90, 750–763.

Electrospun Technology for Drug Delivery and Biomedical Applications
91
Biomaterials. 2016, 83, 169–181.
Delivery Systems. Int. J. Pharm. 2013, 450 (1–2), 145–162.
Colloids Surf. B. 2007, 58 (2), 172–179.
and Biosensing. ACS Biomater. Sci. Eng. 2019, 5 (9), 4183–4205.
Mater. Sci.
Eng. C 2019, 94, 86–93.
Nanomaterials 2019, 9 (4), 656.
Biomaterials 2006,
27 (19), 3631–368.
Biomaterials 2017, 149, 51–62.
and Prognosis. Ebiomedicine 2022, 83, 104237.
Polymers 2016, 8 (2), 42.
Hybrid Constructs. Biomacromolecules 2008, 9 (8), 2097–2103.
Nanosc. Horizons 2022, 7 (11),
1279–1298.
Cardiac Patches. Proc. Natl. Acad. Sci. 2017, 114 (8), 1898–903.
Small 2018, 14 (33), 1801183.
J. Biomed. Mater. Res. Part B: Appl.
Biomater. 2015, 103 (1), 39–46.
J. Drug Targeting. 2015, 23 (3), 202–221.
Colloids Surf. A. 2022, 636, 128163.
Int. J. Pharm.
2015, 494 (1), 278–287.

92
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
A Comparative Study. Mater. Sci. Eng. C 2015, 46, 348–358.
Nanomedicine 2019, 17, 124–136.
Molecules (Basel, Switzerland) 2021, 26 (4), 860.
Drug Delivery. J. Controlled Release 2016, 240, 77–92.
the Dynamics, Spatial Coordination, and Individual Cells Driving Emergent Behaviors.
Biomaterials 2020, 255, 120189.
ACS Appl. Mater. Interfaces.
2017, 9 (13), 11858–11865.
Macromol. Mater. Eng. 2020, 305 (11),
2000230.
Chem. Eng. J. 2020, 385, 123464.
Blood Vessels. Acta Biomater. 2012, 8 (7), 2659–2669.
Engineering. Int. J. Mol. Sci. 2019, 20 (24).
J. Appl. Phys. 1979, 50
(4), 2614–2617.
J. Drug Delivery Sci.
Technol. 2022, 77, 103916.
RSC Adv . 2015, 5 (121), 100256–100267.
J. Biomater.
Sci. Polym. Ed. 2013, 24 (8), 972–985.
J. Controlled Release 2014, 185, 12–21.
Mater. Design 2021, 212, 110240.
Acta Biomater . 2010, 6 (1), 102–109.

Electrospun Technology for Drug Delivery and Biomedical Applications
93
Macromol. Biosci. 2019, 19 (2), 1800412.
J. Controlled Release. 2014, 193,
296–303.
RSC Adv. 2014, 4 (88),
47570–47575.
Adv. Composit. Hybrid Mater.
2022, 5 (4), 3045–3056.
Biomedical Applications. Mater. Sci. Eng. C 2014, 45, 659–670.
Pharm. Dev. Technol. 2014, 19 (3), 269–277.
Biomaterials for Vasculogenesis and Angiogenesis
2022.
Engineering and Regenerative Medicine. Nanomater. Nanotechnol. Med. 2022. 279–302.
Cellulose 2015, 22, 1389–400.
J. Func. Biomater.
2021, 12 (4), 61.
Adv. Drug. Deliv. Rev. 2009, 61 (12), 1020–1032.
Acta Biomater. 2011,
7 (11), 3868–3876.
Chinese Medicine. Nanoscale 2015, 7 (30), 13075–13087.
(l-Lactide-Co-Caprolactone) Fibers by Emulsion Electrospinning. Colloids Surf. B. 2010,
75 (2), 418–424.
Mater. Sci. Eng.
C 2016, 68, 177–183.
Mater. Sci. Eng. C 2017, 74, 117–123.
J.
Nanobiotechnol. 2022, 20 (1), 327.

94
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Prog. Polym. Sci. 2018, 77, 69–94.
Polymers
2022, 14 (10), 2123.
Regeneration. Front. Pharmacol. 2020, 11.
Colloids Surf. B.
2019, 181, 143–148.
Engineering. RSC Adv. 2022, 12 (19), 11913–11922.
Adv.
Healthc. Mater. 2012, 1 (1), 10–25.
Fibrous Mats. Int. J. Pharm. 2017, 529 (1–2), 371–380.
and Solvent Composition. Pharm. Res. 2017, 34, 738–749.
Gels
2022, 8 (6), 357.
Small 2009, 5 (21), 2349–2370.
J.
Biomater. Sci.; Polym. Ed. 2018, 29 (7–9), 805–824.
Int. J. Pharm. 2020, 583, 119364.
IOP Conference
Series: Materials Science and Engineering IOP Publishing, 2016.
Dent.
Mater. 2022, 38 (6), 960–977.
Biomacromolecules
2012, 13 (4), 952–962.
Membranes 2021, 11 (9), 702.
Applications: In V itro Study. Int. J. Polym. Mater. Polym. Biomater. 2015, 64 (9), 474–480.

Electrospun Technology for Drug Delivery and Biomedical Applications
95
Int. J. Biol. Macromol. 2023, 238, 124098.
Skeletal Muscle Regeneration. Front. Bioeng. Biotechnol. 2020, 8, 203.
Nanomaterials
2020, 10 (8), 1609.
J. Pharm. Sci. 2022, 111 (9),
2531–2539.
Electrospun-Based Systems in Cancer Therapy.
Electrospun Materials for Tissue Engineering and Biomedical Applications
2017, pp 337–356.
Pharmaceutics 2019, 11 (7), 305.
Head Neck. 2021, 43 (3), 833–848.
. J.
Biomed. Mater. Res. B Appl. Biomater. 2020, 108 (6), 2528–2537.
Regen. Biomater. 2017, 4 (4), 257–268.
Int. J. Pharm. 2015, 484 (1–2), 57–74.
Delivery Applications. J. Nanomater. 2013, 2013.
Int. J. Pharm. 2019, 558,
268–283.
Int. J. Nanomed. 2019, 14, 4333–4351.
Smart Mater. Med. 2021,
2, 260–279.
Regeneration and Angiogenesis. Adv. Sci. 2018, 5 (4), 1700499.
Acta Biomater. 2017, 51, 138–147.

96
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Angiogenesis. J. Biomed. Mater. Res. A 2019, 107 (9), 2040–2052.
2021, 117, 100721.
Engineering. In Biomaterials Science
J. Biomed. Mater. Res. A 2017, 105 (8), 2119–2128.
Application in Diabetic Wound Healing. Polym. Degrad. Stab. 2020, 174, 109105.
Parameters. 2017, 46 (5), 1170–1192.
Biomed.
Eng. Lett. 2020, 10, 149–161.
Methods. Biomaterials 2016, 106, 24–45.
Adv. Drug. Deliv. Rev. 2016, 107, 206–212.
Curr. Opin. Biomed. Eng. 2020, 13,
1–8.
Tissue Engineering in Oral and
Maxillofacial Surgery;
Mater. Today Chem.
2022, 26, 101025.
Osseointegration Enhancer and Controlled Drug Release Device. Biofabrication 2013, 5
(3), 035006.
Membrane. Int. J. Nanomedicine. 2019, 14, 1835–1847.
Small Sci. 2021, 1 (7), 2100003.
Bull. Mater. Sci. 2016, 39,
337–343.

Electrospun Technology for Drug Delivery and Biomedical Applications
97
Regeneration. Adv. Funct. Mater. 2017, 27 (2), 1604617.
Nanoporous Fibers. Therm. Sci. 2014, 18 (5), 1447–1449.
Mate. Design 2020, 194, 108849.
Eur. J. Pharm. Sci. 2017, 107, 148–67.
Parameters and Solution Properties. J. Macromol. Sci. B. 2011, 50 (8), 1535–1558.
Nanobiomater. Soft Tissue Eng. 2016, 201–229.
Int. J.
Nanomed. 2006, 1 (1), 15–30.
Diabetic W ound Recovery. J. Membr. Sci. 2020, 598, 117648.
Acta Biomater. 2012, 8 (4), 1551–1559.
J. Polym. Res. 2011,
18, 111–123.
Biomolecules. Adv. Mater. Res. 2012, Trans Tech Publ.
ACS Appl. Mater. Interfaces 2018, 10 (2),
1566–1574.
Alignment and Elongation. Acta Biomater. 2019, 96, 175–187.
Engineering. Mater. Today. 2013, 16 (6), 229–241.
Acta
Biomater. 2015, 23, 189–200.
Engineering. Front. Bioeng. Biotechnol. 2019, 7, 127.
J. Mater. Sci. Mater. Med. 2018, 29, 1–12.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
